Karbowniczek M, Spittle CS, Morrison T, Wu H, Henske EP
A summary of clinically-significant GLP-1RAs described in this text and their clinical uses are listed in Table 1
Leigh Purvis, director of health-care costs and access for AARPs Public Policy Institute, believes this is due to intentional misdirection on the part of drugmakers who are eager to divert blame from their own pricing activity
For patients on weekly dosing (irrespective of indication, dose, or type of surgery), consider holding the GLP-1 agonist a week prior to procedure/surgery
The process is designed to be simple, but it still includes a medical evaluation to determine whether Mounjaro, tirzepatide, or another treatment option may be appropriate
However, its important to note that not all studies support the weight loss effects of EGCG, caffeine, and green tea